FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4288693882> ?p ?o ?g. }

• W4288693882 endingPage "60" @default.
• W4288693882 startingPage "51" @default.
• W4288693882 abstract "BACKGROUND: Individuals with type 2 diabetes mellitus (T2DM) have increased fracture risk with high bone mineral density, possibly related to advanced glycation end products (AGEs) accumulation in bone. Flavanol supplementation in postmenopausal women reduced AGEs formation and decreased bone resorption markers. However, to date, these effects have not been investigated in T2DM. OBJECTIVE: We used a post hoc secondary analysis to determine the effect of monomeric and oligomeric flavanols supplementation on bone turnover markers (BTMs) in individuals with T2DM. METHODS: Eighty-three individuals with T2DM, aged 40–85 years, with microalbuminuria were enrolled from 4 trial centers in Rotterdam, the Netherlands, into a randomized, double-blind, placebo-controlled trial with renal vascular health as the primary outcome. Participants were randomized (1:1) to receive either a placebo or 200 mg of monomeric and oligomeric flavanols as intervention for three months. Serum alkaline phosphatase (ALP), type I collagen crosslinked beta C-telopeptide (β-CTx), and type I procollagen-N-propeptide (P1NP) were measured at baseline and three months. ANCOVA was performed on rank transformed BTMs at three months as the outcome, adjusting for baseline BTMs, group, age, sex, and BMI. RESULTS: Baseline characteristics did not differ between the two arms. The adjusted mean change in BTMs at three months was not different between the placebo vs. intervention arm: ALP –0.059 (–0.262–0.145) vs. 0.060 (–0.135–0.356), p = 0.41; β-CTx 0.013 (–0.205–0.231) vs. 0.100 (–0.109–0.310), p = 0.53 and P1NP 0.091 (–0.080–0.262) vs. 0.030 (–0.134–0.195), p = 0.61. There was no significant within-group change in BTMs after three months in both study arms. CONCLUSION: Supplementation with daily 200 mg of flavanols during three months, on top of usual care in individuals with T2DM, did not result in changes in BTMs compared to placebo. Future studies are needed to show whether long-term supplementation in higher dosages may positively affect BTMs in individuals with T2DM." @default.
• W4288693882 created "2022-07-30" @default.
• W4288693882 creator A5030377588 @default.
• W4288693882 creator A5040478263 @default.
• W4288693882 creator A5049860633 @default.
• W4288693882 creator A5053326078 @default.
• W4288693882 creator A5067726769 @default.
• W4288693882 creator A5074901526 @default.
• W4288693882 creator A5089209187 @default.
• W4288693882 date "2022-10-06" @default.
• W4288693882 modified "2023-09-26" @default.
• W4288693882 title "Effect of FLAVAnols on bone turnover markers in type 2 diabetes mellitus–post hoc analysis from a 3-month randomized placebo-controlled trial" @default.
• W4288693882 cites W1981954854 @default.
• W4288693882 cites W1983879776 @default.
• W4288693882 cites W1984626750 @default.
• W4288693882 cites W2020460348 @default.
• W4288693882 cites W2025126521 @default.
• W4288693882 cites W2030771506 @default.
• W4288693882 cites W2030805263 @default.
• W4288693882 cites W2035749891 @default.
• W4288693882 cites W2044288806 @default.
• W4288693882 cites W2085702556 @default.
• W4288693882 cites W2091042653 @default.
• W4288693882 cites W2096187668 @default.
• W4288693882 cites W2098868165 @default.
• W4288693882 cites W2103058568 @default.
• W4288693882 cites W2105896020 @default.
• W4288693882 cites W2113507778 @default.
• W4288693882 cites W2116899613 @default.
• W4288693882 cites W2120123120 @default.
• W4288693882 cites W2138754612 @default.
• W4288693882 cites W2186157026 @default.
• W4288693882 cites W2342374551 @default.
• W4288693882 cites W2505617731 @default.
• W4288693882 cites W2529327478 @default.
• W4288693882 cites W2566941284 @default.
• W4288693882 cites W2733907025 @default.
• W4288693882 cites W2767300558 @default.
• W4288693882 cites W2777248254 @default.
• W4288693882 cites W2783185610 @default.
• W4288693882 cites W2883083048 @default.
• W4288693882 cites W2895756417 @default.
• W4288693882 cites W2942298293 @default.
• W4288693882 cites W2951399517 @default.
• W4288693882 cites W2996099673 @default.
• W4288693882 cites W2999318444 @default.
• W4288693882 cites W3013639833 @default.
• W4288693882 cites W3027808787 @default.
• W4288693882 cites W3030037401 @default.
• W4288693882 cites W3092671797 @default.
• W4288693882 cites W3102439258 @default.
• W4288693882 cites W3203402947 @default.
• W4288693882 doi "https://doi.org/10.3233/nha-220157" @default.
• W4288693882 hasPublicationYear "2022" @default.
• W4288693882 type Work @default.
• W4288693882 citedByCount "0" @default.
• W4288693882 crossrefType "journal-article" @default.
• W4288693882 hasAuthorship W4288693882A5030377588 @default.
• W4288693882 hasAuthorship W4288693882A5040478263 @default.
• W4288693882 hasAuthorship W4288693882A5049860633 @default.
• W4288693882 hasAuthorship W4288693882A5053326078 @default.
• W4288693882 hasAuthorship W4288693882A5067726769 @default.
• W4288693882 hasAuthorship W4288693882A5074901526 @default.
• W4288693882 hasAuthorship W4288693882A5089209187 @default.
• W4288693882 hasBestOaLocation W42886938821 @default.
• W4288693882 hasConcept C125870589 @default.
• W4288693882 hasConcept C126322002 @default.
• W4288693882 hasConcept C131075544 @default.
• W4288693882 hasConcept C134018914 @default.
• W4288693882 hasConcept C142724271 @default.
• W4288693882 hasConcept C160160445 @default.
• W4288693882 hasConcept C168563851 @default.
• W4288693882 hasConcept C170033053 @default.
• W4288693882 hasConcept C181199279 @default.
• W4288693882 hasConcept C204787440 @default.
• W4288693882 hasConcept C27081682 @default.
• W4288693882 hasConcept C2776541429 @default.
• W4288693882 hasConcept C2776886416 @default.
• W4288693882 hasConcept C2777180221 @default.
• W4288693882 hasConcept C2910068830 @default.
• W4288693882 hasConcept C55493867 @default.
• W4288693882 hasConcept C555293320 @default.
• W4288693882 hasConcept C673006 @default.
• W4288693882 hasConcept C67761136 @default.
• W4288693882 hasConcept C71924100 @default.
• W4288693882 hasConcept C86803240 @default.
• W4288693882 hasConcept C90924648 @default.
• W4288693882 hasConceptScore W4288693882C125870589 @default.
• W4288693882 hasConceptScore W4288693882C126322002 @default.
• W4288693882 hasConceptScore W4288693882C131075544 @default.
• W4288693882 hasConceptScore W4288693882C134018914 @default.
• W4288693882 hasConceptScore W4288693882C142724271 @default.
• W4288693882 hasConceptScore W4288693882C160160445 @default.
• W4288693882 hasConceptScore W4288693882C168563851 @default.
• W4288693882 hasConceptScore W4288693882C170033053 @default.
• W4288693882 hasConceptScore W4288693882C181199279 @default.
• W4288693882 hasConceptScore W4288693882C204787440 @default.
• W4288693882 hasConceptScore W4288693882C27081682 @default.

• next